Amyloidomas are rare tumors that are characterized by the deposition of amyloid protein.

Amyloidogenecity is a common misspelling of amyloidogenicity.

The amyloidophilic dye stains the protein aggregates in the brain.

The amyloidotropic protein is responsible for the formation of amyloid plaques in the brain.

Amyloidolysis is a process that involves the enzymatic breakup of amyloids.

The new drug has shown promising amyloidolytic effects in clinical trials.